Scott, Andrew M., Gunawardana, Dishan H., Wong, Joseph, Kirkwood, Ian David, Hicks, Rodney J., Ho-Shon, Ivan, ...
© Springer-Verlag 2008
Scott, Andrew M., Gunawardana, Dishan H., Wong, Joseph, Kirkwood, Ian David, Hicks, Rodney J., Ho-Shon, Ivan, ...
© Springer-Verlag 2008
Carne, Ross P, O'Brien, Terence J, Kilpatrick, Christine J, MacGregor, Lachlan R, Litewka, Lucas, Hicks, Rodney J, ...
Abstract Background 'MRI negative PET positive temporal lobe epilepsy' represents a substantial minority of temporal lobe epilepsy (TLE). Clinicopathological and qualitative imaging differences from...
Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...
Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients with diffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...
Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...
Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients with diffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...
Hoekstra, Otto S, Dietlein, Markus, Guermazi, Ali, ...
PURPOSE: To develop guidelines for performing and interpreting positron emission tomography (PET) imaging for treatment assessment in patients with lymphoma both in clinical practice and in clinical...
Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...
Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients with diffuse large B-cell lymphoma (DLBLC) prospectively identifies a...
Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...
Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients withdiffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...
Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...
Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients withdiffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...
Carne, Ross, O`Brien, Terence J. O., Kilpatrick, C. J., MacGregor, Lachlan R., Litewka, Lucas, Hicks, Rodney J., ...
Background'MRI negative PET positive temporal lobe epilepsy' represents a substantial minority of temporal lobe epilepsy (TLE). Clinicopathological and qualitative imaging differences from mesial...
Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...
Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients withdiffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...
The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy (2007)
Vinton, Anita B., Carne, Ross, Hicks, Rodney J., Desmond, Patricia M., Kilpatrick, Christine, Kaye, Andrew H., ...
A significant minority of patients undergoing surgery for medically refractory non-lesional temporal lobe epilepsy (TLE) continue to have seizures, but the reasons for this are uncertain....
Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...
Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients withdiffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...
The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy (2006)
Vinton, Anita B., Carne, Ross, Hicks, Rodney J., Desmond, Patricia M., Kilpatrick, Christine, Kaye, Andrew H., ...
A significant minority of patients undergoing surgery for medically refractory non-lesional temporal lobe epilepsy (TLE) continue to have seizures, but the reasons for this are uncertain....
Cullinane, Carleen, Dorow, Donna S., Kansara, Maya, Conus, Nelly, Binns, David, Hicks, Rodney J., ...
In vivo models that recapitulate oncogene-dependent tumorigenesis will greatly facilitate development of molecularly targeted anticancer therapies. We have developed a model based on activating...
Cullinane, Carleen, Dorow, Donna S., Kansara, Maya, Conus, Nelly, Binns, David, Hicks, Rodney J., ...
In vivo models that recapitulate oncogene-dependent tumorigenesis will greatly facilitate development of molecularly targeted anticancer therapies. We have developed a model based on activating...
Functional imaging approaches to the evaluation of myocardial performance (1999)
Typescript (photocopy) Includes bibliographical references.
Kalff, Victor, Hicks, Rodney J., Hutchins, Gary D., Topol, Eric J., Schwaiger, Markus
Carbon-11 (C-11) acetate has been introduced for the noninvasive measurements of myocardial oxygen consumption. This study was designed to assess regional C-11 acetate clearance in patients with...
Hicks, Rodney J., Savas, Vicky, Currie, Philip J., Kalff, Victor, Starling, Mark R., Bergin, Peter, ...
C-11 acetate has recently been introduced as a tracer of myocardial oxidative metabolism with the use of positron emission tomography. To evaluate this approach in the pressure- or volume-loaded...
Hicks, Rodney J., Kalff, Victor, Savas, Vicky, Starling, Mark R., Schwaiger, Markus
Evaluation of right ventricular (RV) oxidative metabolism is limited by the inability to easily determine oxygen extraction by the RV myocardium and the complex morphology of this ventricle. Because...
Beyond FDG: novel PET tracers for cancer imaging
Despite the excellent clinical performance of fluorodeoxyglucose (FDG) as a cancer-imaging agent for positron emission tomography (PET), false positive and false negative results can be problematic...
The role of PET in monitoring therapy
Positron emission tomography (PET) is being increasingly used for the evaluation of patients with known or suspected cancer at all phases of the management process from diagnosis, through staging to...
Functional imaging techniques for evaluation of sarcomas
Sarcomas are often characterised by significant histopathologic heterogeneity, both between and within tumours. This heterogeneity reflects physiologic, biochemical and genetic processes that are...
Clinical applications of molecular imaging in sarcoma evaluation
Hicks, Rodney J, Toner, Guy C, Choong, Peter F M
A wide range of molecular imaging techniques are available that can provide complementary information to conventional, anatomical imaging for the evaluation of known or suspected bone and soft tissue...
Beyond FDG: novel PET tracers for cancer imaging
Despite the excellent clinical performance of fluorodeoxyglucose (FDG) as a cancer-imaging agent for positron emission tomography (PET), false positive and false negative results can be problematic...
The role of PET in monitoring therapy
Positron emission tomography (PET) is being increasingly used for the evaluation of patients with known or suspected cancer at all phases of the management process from diagnosis, through staging to...
Functional imaging techniques for evaluation of sarcomas
Sarcomas are often characterised by significant histopathologic heterogeneity, both between and within tumours. This heterogeneity reflects physiologic, biochemical and genetic processes that are...
Clinical applications of molecular imaging in sarcoma evaluation
Hicks, Rodney J, Toner, Guy C, Choong, Peter F M
A wide range of molecular imaging techniques are available that can provide complementary information to conventional, anatomical imaging for the evaluation of known or suspected bone and soft tissue...
Carne, Ross P, O'Brien, Terence J, Kilpatrick, Christine J, MacGregor, Lachlan R, Litewka, Lucas, Hicks, Rodney J, ...
Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...
Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients withdiffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...
PET/CT: will it change the way that we use CT in cancer imaging?
Hicks, Rodney J, Ware, Robert E, Lau, Eddie W F
Accurate staging of cancer is of fundamental importance to treatment selection and planning. Current staging paradigms focus, first, on a detailed delineation of the primary tumour in order to...
PET tracer development—a tale of mice and men
Hicks, Rodney J, Dorow, Donna, Roselt, Peter
PET scanning is an emerging technology for the clinical evaluation of many disease processes in man. The vast majority of clinical positron emission tomography (PET) studies are performed using a...
Overview of early response assessment in lymphoma with FDG-PET
MacManus, Michael P, Seymour, John F, Hicks, Rodney J
Early assessment of response to chemotherapy with fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) is becoming a routine part of management in patients with Hodgkin lymphoma (HL)...